| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| | 10-K | 10-K | 10-K | 10-K | 10-K |
| Cash flows from operating activities: | | | | | |
| Net income (loss) | -178.0 | -212.0 | -262.0 | 152.0 | -1.0 |
| Adjustments to reconcile net income (loss) to net cash from (used in) operating activities: | | | | | |
| Depreciation and amortization | 159.0 | 181.0 | | | |
| Amortization of deferred costs and other assets | 12.0 | 22.0 | | | |
| Gain on casualty | -5.0 | -2.0 | | | |
| Equity-based compensation expense | 10.0 | 11.0 | 11.0 | 16.0 | 14.0 |
| Impairment loss | 54.0 | 141.0 | 154.0 | 1.0 | 104.0 |
| Deferred income tax expense | -6.0 | -1.0 | 6.0 | -112.0 | -12.0 |
| Changes in assets and liabilities: | | | | | |
| Accounts receivable | 8.0 | -9.0 | 9.0 | 2.0 | -9.0 |
| Other assets | 7.0 | 9.0 | -11.0 | -31.0 | 3.0 |
| Accounts payable and accrued expenses | -28.0 | 2.0 | 14.0 | -7.0 | 12.0 |
| Other liabilities | | 6.0 | 3.0 | 2.0 | 1.0 |
| Net cash provided by (used in) operating activities | -38.0 | 116.0 | 111.0 | 182.0 | 264.0 |
| |
| Cash flows from investing activities: | | | | | |
| Capital expenditures, primarily investments in existing real estate | -24.0 | -74.0 | -167.0 | -218.0 | -144.0 |
| Lender and other escrows | -10.0 | 5.0 | -20.0 | | |
| Insurance proceeds related to real estate casualties | 15.0 | 11.0 | 25.0 | 6.0 | 5.0 |
| Net cash provided by investing activities | 229.0 | 103.0 | -156.0 | -181.0 | -70.0 |
| |
| Cash flows from financing activities: | | | | | |
| Proceeds from debt | 110.0 | | 1,060.0 | | |
| Repayment of debt | -221.0 | -114.0 | -1,030.0 | -18.0 | -18.0 |
| Debt issuance costs | -1.0 | | -30.0 | | |
| Payment of insurance financing | -14.0 | -11.0 | | | |
| Dividends on common stock | -22.0 | -46.0 | -16.0 | | |
| Purchase of common stock | -1.0 | -31.0 | -6.0 | -3.0 | -102.0 |
| Net cash used in financing activities | -149.0 | -186.0 | -28.0 | -21.0 | -120.0 |
| |
| The following table provides a reconciliation of cash, cash equivalents and restricted cash within the condensed consolidated balance sheets to the amount shown in the condensed consolidated statements of cash flows: | | | | | |
| Cash and cash equivalents | | | | | |
| Restricted cash (included in other assets) | | | | | |